David D. Chang
Impact in
- Oncology top 0.2%
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- RNA and protein synthesis mechanisms 17
- Mitochondrial Function and Pathology 15
- Metabolomics and Mass Spectrometry Studies 11
- RNA modifications and cancer 10
- RNA Research and Splicing 8
-
- Metabolism and Genetic Disorders 7
- Co-authors
- David A. Clayton (16 shared papers)Phillip A. Sharp (1 shared paper)Scott Donald Patterson (3 shared papers)Rafael G. Amado (2 shared papers)Todd Juan (3 shared papers)Robert Radinsky (2 shared papers)Michael Wolf (3 shared papers)Robert S. Sikorski (2 shared papers)
- Journals
- Molecular and Cellular Biology (8 papers)Proceedings of the National Academy of Sciences (4 papers)Cell (3 papers)Oncogene (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
David D. Chang
81 papers receiving 14.7k citations
David D. Chang's Hit Papers
Peers
Comparison fields: 5 of 164
- Oncology 7.0k
- Pathology and Forensic Medicine 1.6k
- Molecular Biology 6.5k
- Virology 389
- Clinical Biochemistry 552
Countries citing papers authored by David D. Chang
This map shows the geographic impact of David D. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Chang more than expected).
Fields of papers citing papers by David D. Chang
This network shows the impact of papers produced by David D. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Chang. The network helps show where David D. Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside David D. Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma Hit paper breakdown → | 2017 | 4744 |
| 2 | Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 2663 |
| 3 | 1998 | 634 | |
| 4 | Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. | 2002 | 512 |
| 5 | 2010 | 498 | |
| 6 | 1989 | 450 | |
| 7 | 2007 | 357 | |
| 8 | 1991 | 348 | |
| 9 | 1998 | 309 | |
| 10 | 1985 | 287 | |
| 11 | 1987 | 285 | |
| 12 | 1984 | 259 | |
| 13 | 1987 | 224 | |
| 14 | 2011 | 199 | |
| 15 | 1991 | 198 | |
| 16 | 1985 | 175 | |
| 17 | 1989 | 173 | |
| 18 | 2007 | 165 | |
| 19 | 1997 | 156 | |
| 20 | 2022 | 150 |
About David D. Chang
David D. Chang is a scholar working on Molecular Biology, Clinical Biochemistry, Immunology and Allergy, Oncology and Cell Biology, having authored 82 papers that have together received 15.2k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (17 papers), Mitochondrial Function and Pathology (15 papers), Metabolomics and Mass Spectrometry Studies (11 papers), RNA modifications and cancer (10 papers), RNA Research and Splicing (8 papers), Cellular Mechanics and Interactions (7 papers), Metabolism and Genetic Disorders (7 papers) and Cell Adhesion Molecules Research (6 papers). The work is most often cited by research in Oncology (7.0k citations), Pathology and Forensic Medicine (1.6k citations), Molecular Biology (6.5k citations), Virology (389 citations) and Clinical Biochemistry (552 citations). David D. Chang has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include David A. Clayton, Phillip A. Sharp, Scott Donald Patterson, Rafael G. Amado, Todd Juan, Robert Radinsky, Michael Wolf, Robert S. Sikorski, Daniel J. Freeman and Eric Van Cutsem. Their work appears in journals such as Molecular and Cellular Biology, Proceedings of the National Academy of Sciences, Cell, Oncogene and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.